SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-341829
Filing Date
2017-11-14
Accepted
2017-11-14 08:23:48
Documents
42
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d469644d10q.htm 10-Q 232271
2 EX-10.1 d469644dex101.htm EX-10.1 7647
3 EX-10.2 d469644dex102.htm EX-10.2 8057
4 EX-10.3 d469644dex103.htm EX-10.3 8423
5 EX-31.1 d469644dex311.htm EX-31.1 6623
6 EX-31.2 d469644dex312.htm EX-31.2 6600
7 EX-32.1 d469644dex321.htm EX-32.1 4851
  Complete submission text file 0001193125-17-341829.txt   1646041

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT oxgn-20170930.xml EX-101.INS 285657
9 XBRL TAXONOMY EXTENSION SCHEMA oxgn-20170930.xsd EX-101.SCH 22443
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oxgn-20170930_cal.xml EX-101.CAL 26221
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oxgn-20170930_def.xml EX-101.DEF 42371
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE oxgn-20170930_lab.xml EX-101.LAB 188564
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oxgn-20170930_pre.xml EX-101.PRE 119291
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 171198447
SIC: 2836 Biological Products, (No Diagnostic Substances)